Clinical remissions in previously untreated patients with follicular lymphoma after intradermal immunization with a recombinant idiotype vaccine

被引：0
|
作者：
Mikesch, K [1 ]
Bertinetti, C [1 ]
Veelken, H [1 ]
机构：
[1] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] CVP plus rituximab compared to CVP alone in previously untreated patients with follicular lymphoma:: Impact of baseline prognostic factors
    Imrie, K
    Belch, A
    Pettengell, R
    Rueda, A
    McKendrick, J
    Solal-Céligny, P
    Offner, F
    Bence-Buckler, I
    Walewski, J
    Raposo, J
    Marcus, R
    ANNALS OF ONCOLOGY, 2005, 16 : 109 - 110
  • [42] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
    Gao, Fenghua
    Zhang, Tingting
    Liu, Hengqi
    Li, Wei
    Liu, Xianming
    Qiu, Lihua
    Li, Lanfang
    Zhou, Shiyong
    Qian, Zhengzi
    Dong, Sitong
    Zhao, Sai
    Wang, Xianhuo
    Zhang, Huilai
    ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2383 - 2392
  • [43] Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis
    Fenghua Gao
    Tingting Zhang
    Hengqi Liu
    Wei Li
    Xianming Liu
    Lihua Qiu
    Lanfang Li
    Shiyong Zhou
    Zhengzi Qian
    Sitong Dong
    Sai Zhao
    Xianhuo Wang
    Huilai Zhang
    Annals of Hematology, 2022, 101 : 2817 - 2817
  • [44] Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab
    Berinstein, N. L.
    Bhella, S.
    Pennell, N. M.
    Cheung, M. C.
    Imrie, K. R.
    Spaner, D. E.
    Milliken, V.
    Zhang, L.
    Hewitt, K.
    Boudreau, A.
    Reis, M. D.
    Chesney, A.
    Good, D.
    Ghorab, Z.
    Hicks, L. K.
    Piliotis, E.
    Buckstein, R.
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 813 - 823
  • [45] Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab
    N. L. Berinstein
    S. Bhella
    N. M. Pennell
    M. C. Cheung
    K. R. Imrie
    D. E. Spaner
    V. Milliken
    L. Zhang
    K. Hewitt
    A. Boudreau
    M. D. Reis
    A. Chesney
    D. Good
    Z. Ghorab
    L. K. Hicks
    E. Piliotis
    R. Buckstein
    Annals of Hematology, 2015, 94 : 813 - 823
  • [46] PRELIMINARY SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF DUVELISIB PLUS RITUXIMAB OR OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED CD20+FOLLICULAR LYMPHOMA
    Casulo, C.
    Jacobsen, E.
    Van Eygen, K.
    Holmes, H. E.
    Lemmens, J. P.
    Allen, K.
    Steelman, L.
    Campbell, V.
    Nevejans, J.
    Pearlberg, J.
    Goy, A.
    HAEMATOLOGICA, 2016, 101 : 104 - 104
  • [47] Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
    Fischer, Kirsten
    Bahlo, Jasmin
    Fink, Anna Maria
    Goede, Valentin
    Herling, Carmen Diana
    Cramer, Paula
    Langerbeins, Petra
    von Tresckow, Julia
    Engelke, Anja
    Maurer, Christian
    Kovacs, Gabor
    Herling, Marco
    Tausch, Eugen
    Kreuzer, Karl-Anton
    Eichhorst, Barbara
    Boettcher, Sebastian
    Seymour, John F.
    Ghia, Paolo
    Marlton, Paula
    Kneba, Michael
    Wendtner, Clemens-Martin
    Doehner, Hartmut
    Stilgenbauer, Stephan
    Hallek, Michael
    BLOOD, 2016, 127 (02) : 208 - 215
  • [48] Cost-Effectiveness of Obinutuzumab Plus Chemotherapy Versus Rituximab Biosimilars Plus Chemotherapy for Patients with Previously Untreated Follicular Lymphoma
    Veenstra, David L.
    Guzauskas, Gregory F.
    Spencer, Scott J.
    Felizzi, Federico
    Launonen, Aino
    Dawson, Keith
    Masaquel, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S280 - S280
  • [49] Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy
    Sohani, Aliyah R.
    Maurer, Matthew J.
    Giri, Sharmila
    Pitcher, Brandelyn
    Chadburn, Amy
    Said, Jonathan W.
    Bartlett, Nancy L.
    Czuczman, Myron S.
    Martin, Peter
    Rosenbaum, Cara A.
    Jung, Sin-Ho
    Leonard, John P.
    Cheson, Bruce D.
    Hsi, Eric D.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (03) : 384 - 393
  • [50] Randomized comparison of cladribine containing regimens and COP in previously untreated patients with small lymphocytic, marginal zone and follicular lymphoma.
    Kalinka, E
    Wajs
    Sulek, K
    Robak, T
    Blasinska-Morawiec, M
    Sawczuk-Chabin, J
    Ceglarek, B
    Konopka, L
    Centkowski, P
    Seferynska, I
    Warzocha, K
    BLOOD, 2005, 106 (11) : 265B - 265B
12345